346 related articles for article (PubMed ID: 15452864)
1. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
2. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum.
Volz TJ; Bjorklund NL; Schenk JO
Synapse; 2005 Sep; 57(3):175-8. PubMed ID: 15945061
[TBL] [Abstract][Full Text] [Related]
4. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
Kiss JP; Zsilla G; Vizi ES
Neurochem Int; 2004 Sep; 45(4):485-9. PubMed ID: 15186914
[TBL] [Abstract][Full Text] [Related]
6. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
[TBL] [Abstract][Full Text] [Related]
7. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
8. Different response to exogenous L-arginine in nitric oxide production between hippocampus and striatum of conscious rats: a microdialysis study.
Hara S; Mukai T; Kurosaki K; Mizukami H; Kuriiwa F; Endo T
Neurosci Lett; 2004 Aug; 366(3):302-7. PubMed ID: 15288439
[TBL] [Abstract][Full Text] [Related]
9. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
10. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
Zahniser NR; Larson GA; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.
Gerasimov MR; Franceschi M; Volkow ND; Rice O; Schiffer WK; Dewey SL
Synapse; 2000 Dec; 38(4):432-7. PubMed ID: 11044890
[TBL] [Abstract][Full Text] [Related]
12. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
13. Role of the dopamine transporter and the sodium channel in the cocaine-like discriminative stimulus effects of local anesthetics in rats.
Wilcox KM; Paul IA; Ordway GA; Woolverton WL
Psychopharmacology (Berl); 2001 Sep; 157(3):260-8. PubMed ID: 11605081
[TBL] [Abstract][Full Text] [Related]
14. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis.
Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502
[TBL] [Abstract][Full Text] [Related]
15. Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR; Sorkin A
Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
19. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
